Acne and Pregnancy: A Clinical Review and Practice Pearls

Area of Science:

• Dermatology
• Obstetrics
• Pharmacology

Background:

• Acne vulgaris frequently impacts women of childbearing age.
• Pregnancy necessitates careful consideration of acne treatment safety for both maternal and fetal well-being.
• Certain acne medications pose risks during gestation, demanding cautious therapeutic choices.

Purpose of the Study:

• To review the safety profile of common acne treatments during pregnancy.
• To provide practical clinical recommendations for managing acne in pregnant individuals.
• To ensure safe and effective dermatological care throughout the female reproductive journey.

Main Methods:

• Literature review of existing studies on acne pharmacotherapy in pregnancy.
• Analysis of drug safety data pertaining to maternal and fetal outcomes.
• Synthesis of clinical guidelines and expert opinions.

Main Results:

• Identification of generally safe and contraindicated acne medications during pregnancy.
• Discussion of risk-benefit assessments for various treatment options.
• Highlighting topical therapies as often preferred first-line options.

Conclusions:

• Careful selection of acne treatments is critical for pregnant women.
• Dermatologists should be aware of medication safety profiles during pregnancy.
• Implementing evidence-based, safe treatment strategies ensures optimal patient outcomes.